​Bioforum the Data Masters Expands Global Footprint with New Office and GCC in Bengaluru, India

Date:

Share post:

Bioforum the Data Masters, a leading global biometric Contract Research Organization (CRO), announced the opening of its new office and Global Capability Center (GCC) in Bengaluru. The launch represents one of the largest growth initiatives in the company’s history, significantly broadening its worldwide delivery infrastructure.

​The new India GCC integrates key technical capabilities, including clinical data management, statistical programming, clinical coding, validation, clinical standards, and technology solutions. Serving as an integral hub within Bioforum’s global delivery network, the facility strengthens the organization’s follow-the-sun operational model and expands its Functional Service Provider (FSP) delivery model to support biopharmaceutical clients across time zones.

​“Our Global Capability Center in Bangalore significantly strengthens our ability to support complex global programs, expand our FSP delivery capabilities, and provide clients with the expertise and flexibility they need as their programs grow,” said Amir Malka, CEO and Co-Founder of Bioforum.

​The strategic move highlights India’s evolving position as a high-value hub for clinical data science and innovation.

​“India’s role in clinical development has fundamentally changed, from a delivery location to a strategic capability,” added Dr. Santhosh Kumar, Senior Vice President, India and GCC at Bioforum.

​The Bengaluru GCC enhances Bioforum’s capacity to deliver agile, high-quality data solutions for clinical trials worldwide, reinforcing its commitment to end-to-end biometrics excellence and scalable partner support.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Department of Pharmaceuticals Reopens ₹5,000 Crore Pharma Innovation Scheme for Second Round of Applications

India's Department of Pharmaceuticals has opened a fresh application window for its flagship Promotion of Research and Innovation...

40,468 Lives Screened: Alembic Pharmaceuticals Earns Asia Book of Records Recognition

Alembic Pharmaceuticals Limited has been recognized by the Asia Book of Records for conducting one of the largest...

Cipla’s Pithampur Facility Receives 7 FDA Observations Following Inspection

Cipla Limited  announced the conclusion of a routine Current Good Manufacturing Practice (cGMP) inspection conducted by the United States...

Roche Wins FDA Clearance for New Blood Test to Detect Alzheimer’s Disease

Roche has secured U.S. Food and Drug Administration clearance for Elecsys pTau217, a plasma-based blood test designed to help physicians...